FDA Approved: VILTEPSO — Supplemental Application (NS Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VILTEPSO (viltolarsen) from NS Pharma, Inc., resulting in updated labeling for Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Viltepso (viltolarsen)

Snippet

SUPPL AP for VILTEPSO (VILTOLARSEN)